NCT03279562View on ClinicalTrials.gov

Patient Driven Recovery With Nalmefene and Coaching

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Opioid-use DisorderHarmful; Use, Alcohol
Interventions
DRUG

Nalmefene

Educational and behaviorally oriented drug counseling

Trial Locations (1)

06519

Yale University, Department, New Haven

All Listed Sponsors
collaborator

First Pavlov State Medical University in St. Petersburg, Russia

UNKNOWN

lead

Yale University

OTHER

NCT03279562 - Patient Driven Recovery With Nalmefene and Coaching | Biotech Hunter | Biotech Hunter